Particulars |
|
|
|
Company Name
| Piramal Pharma Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
1,325.75 |
B.V. (₹) |
52.90 |
Sales(₹ Cr.) |
4,390.11 |
NP (₹ Cr.) |
387.88 |
NP Var% |
434.00 |
Div% |
1.00 |
CPS(₹) |
4.50 |
EPS (₹) |
2.90 |
Traded Value(₹ Lakhs) |
1,485.08 |
52 Week High |
308.00 |
52 Week Low |
114.00 |
Price BSE |
269.00 |
Price NSE |
269.00 |
Market Capital (₹ Cr.) |
35,636.11 |
P/C Ratio |
60.10 |
P/E Ratio |
91.90 |
Price Vs.BV |
5.09 |
|
Latest Quarter |
Year End |
202409 |
Sales (₹ Cr.) |
1,284.39 |
NP(₹ Cr.) |
210.06 |
NP Var % |
172.00 |
Trailing Twelve Months |
Year End |
202409 |
Sales |
4,897.03 |
OPM |
18.78 |
NP |
642.75 |
NP Var% |
673.65 |
EPS |
4.85 |
PE |
55.42 |
|
|